Quantitative Investment Management Reduces Eli Lilly Stake

Hedge fund cuts position in pharmaceutical giant by 20.8% in Q3

Mar. 13, 2026 at 10:39am

Got story updates? Submit your updates here. ›

Quantitative Investment Management LLC, a hedge fund, decreased its stake in Eli Lilly and Company (NYSE:LLY) by 20.8% during the third quarter, according to a recent 13F filing with the Securities and Exchange Commission. The fund now owns 19,202 shares of the pharmaceutical company's stock, valued at $14.65 million.

Why it matters

Eli Lilly is one of the world's largest pharmaceutical companies, known for its innovative drugs and therapies. Institutional investors like Quantitative Investment Management closely monitor and adjust their positions in Lilly, providing insights into market sentiment around the stock.

The details

Quantitative Investment Management sold 5,034 shares of Eli Lilly during the third quarter, reducing its total position to 19,202 shares. The hedge fund's holdings in Lilly now account for 2.0% of its overall portfolio, making it the 10th largest position. Other notable institutional investors in Eli Lilly include Exencial Wealth Advisors, Central Pacific Bank Trust Division, and Cidel Asset Management.

  • Quantitative Investment Management reduced its Eli Lilly stake during the 3rd quarter of 2026.

The players

Quantitative Investment Management LLC

A hedge fund that decreased its stake in Eli Lilly and Company by 20.8% in the third quarter of 2026.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana, known for its innovative drugs and therapies.

Got photos? Submit your photos here. ›

The takeaway

Quantitative Investment Management's reduction in its Eli Lilly position provides a data point on institutional sentiment around the pharmaceutical giant, though the reasons behind the hedge fund's move are not explicitly stated in the report.